NCT06075849: Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent |
|
|
| Recruiting | 1 | 30 | RoW | PB101 | Panolos Bioscience | Solid Tumor, Adult, Solid Tumor, Gastric Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer, Advanced Solid Tumor | 10/24 | 01/25 | | |
